Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects
- PMID: 1246330
- DOI: 10.1056/NEJM197602262940901
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects
Abstract
Glucagon was infused to maintain plasma concentrations three to six times the basal level (300 to 600 pg per milliliter) into 16 normal and seven non-diabetic obese subjects. Hyperglucagonemia caused only a transient rise of 5 to 10 mg per 100 ml in basal glucose levels and had no effect on oral glucose tolerance or plasma insulin. In three patients with adult and two with juvenile-onset diabetes on maintenance insulin, hyperglucagonemia maintained for two to four days caused no change in plasma glucose of ketone concentration. In contrast, in nine insulin-withdrawn patients the glycemic response to hyperglucagonemia was five to 15 times greater (P less then 0.05) than in normal controls. Hyperglucagonemia does not cause glucose intolerance in normal subjects or bring about deterioration of diabetic control when insulin is available. Glucagon in the insulin-deprived patient can worsen the diabetic state. These findings suggest the primary role of insulin deficiency in the diabetogenic action of glucagon.
Similar articles
-
Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.J Clin Invest. 1979 May;63(5):849-57. doi: 10.1172/JCI109384. J Clin Invest. 1979. PMID: 447832 Free PMC article.
-
Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.J Clin Invest. 1979 Jun;63(6):1119-23. doi: 10.1172/JCI109404. J Clin Invest. 1979. PMID: 447838 Free PMC article.
-
Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.Diabete Metab. 1988 Jul-Aug;14(4):443-51. Diabete Metab. 1988. PMID: 3066652
-
Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.Curr Hypertens Rep. 2013 Oct;15(5):522-30. doi: 10.1007/s11906-013-0383-y. Curr Hypertens Rep. 2013. PMID: 23996678 Free PMC article. Review.
-
Glucagon and diabetes.Med Clin North Am. 1978 Jul;62(4):713-22. doi: 10.1016/s0025-7125(16)31767-9. Med Clin North Am. 1978. PMID: 355737 Review.
Cited by
-
Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.J Clin Invest. 1979 May;63(5):820-7. doi: 10.1172/JCI109381. J Clin Invest. 1979. PMID: 447830 Free PMC article.
-
Hormonal regulation of hepatic glucose production in health and disease.Cell Metab. 2011 Jul 6;14(1):9-19. doi: 10.1016/j.cmet.2011.06.003. Cell Metab. 2011. PMID: 21723500 Free PMC article. Review.
-
Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.Diabetologia. 1979 Sep;17(3):139-43. doi: 10.1007/BF01219739. Diabetologia. 1979. PMID: 510828 No abstract available.
-
Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.J Clin Invest. 1979 Jan;63(1):114-23. doi: 10.1172/JCI109264. J Clin Invest. 1979. PMID: 762240 Free PMC article.
-
Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes.Diabetes. 2011 Aug;60(8):2160-8. doi: 10.2337/db11-0251. Epub 2011 Jun 15. Diabetes. 2011. PMID: 21677283 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources